Baird Releases Bullish Note on Regeneron (REGN), Eylea Taking Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Brean Capital Downgrades Regeneron Pharma (REGN) to Hold
January 17, 2013 8:23 AM ESTBrean Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Hold saying it would be increasingly difficult for the company to substantially beat consensus as it had quite easily throughout 2012, regardless of a new indication and ex-U.S. approvals.
For an analyst... More
Jefferies Downgrades Regeneron Pharma (REGN) to Hold, Sees Limited Eylea Upside
January 15, 2013 7:12 AM ESTJefferies downgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Hold with a price target of $179.00.
The firm sees limited Eylea upside after conducting another wAMD survey. The firm said the current stock prices adequately reflects anticipated growth. Benefit from potential cmpding driven... More
